Chinese Obesity and MEtabolic Surgery Database (COMES Database)
Launched by JINAN UNIVERSITY GUANGZHOU · Feb 21, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Chinese Obesity and Metabolic Surgery Database (COMES Database) is a study that looks into how effective weight loss surgeries, known as metabolic and bariatric surgeries, are for people with obesity and related health issues in China. The goal is to gather information that helps understand the long-term benefits and challenges of these surgeries.
If you have been diagnosed with obesity and are considering weight loss surgery, you might be eligible to participate in this trial. The study is open to individuals of all ages and genders who are planning to undergo surgical treatment for obesity. Unfortunately, if you've been treated with non-surgical methods for weight loss, you won't be able to join. Participants in this study can expect to provide information about their health over time, helping researchers learn more about how these surgeries impact patients in the long run. Your involvement could help improve care for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed as obesity undergoing metabolic and bariatric surgery.
- Exclusion Criteria:
- • Patients treated by non-surgical modalities.
About Jinan University Guangzhou
Jinan University Guangzhou is a prestigious academic institution known for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources, state-of-the-art facilities, and a collaborative network of researchers and healthcare professionals to conduct innovative studies aimed at improving patient outcomes. With a focus on multidisciplinary approaches, Jinan University Guangzhou emphasizes ethical practices and regulatory compliance in its clinical trials, fostering an environment conducive to groundbreaking discoveries in the biomedical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Cunchuan Wang, MD, PhD
Study Chair
First Affiliated Hospital of Jinan University
Wah Yang, MD
Study Director
First Affiliated Hospital of Jinan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported